Who owns Carmell Therapeutics Corp - US?

Tip: Access positions for across all investors

Analyze quarterly positions in Carmell Therapeutics Corp - US with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Carmell Therapeutics Corp - US stock

Who bought or sold Carmell Therapeutics Corp - US this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Balyasny Asset Management 343k $79k 0% Dec 2023
 View chart
Millennium Management 235k $59k -1% Dec 2023
 View chart
OZ Management 228k $51k 0% Dec 2023
 View chart
Highbridge Capital Management 182k $42M 0% Dec 2023
 View chart
Exos TFP Holdings 130k $30k 0% Dec 2023
 View chart
CNH Partners 96k $22k -1% Dec 2023
 View chart
Walleye Trading Advisors 51k $12k 0% Dec 2023
 View chart
Cowen And Company 25k $6.3k -88% Dec 2023
 View chart
Flow Traders US 20k $4.0k -1% Dec 2023
 View chart
Saba Capital Management 20k $4.4k 0% Dec 2023
 View chart
Whitebox Advisors 19k $4.7k 0% Dec 2023
 View chart
Wolverine Asset Management 11k $2.7k 72% Dec 2023
 View chart
Ancora Advisors 2.8k $622.951200 0% Dec 2023
 View chart

Who sold out of Carmell Therapeutics Corp - US?

Fund or Company Name Date Sold Shares Held Valued At
DeepCurrents Investment Group Sep 2023 8.7k $32k